
Sanofi plans to create a new company in Europe dedicated to the production and marketing of active pharmaceutical ingredients (API). …

Teva Pharmaceuticals has expanded its recall of losartan potassium tablets after detecting a possible carcinogen in an active pharmaceutical ingredient …

British multinational GlaxoSmithKline has opened an API manufacturing plant in Montrose Scotland for its Ellipta respiratory medicines. The new facility …

Penn Pharma has opened its expanded facility in South Wales, after a £3 million investment which will allow it to …

Novo Nordisk says it will invest around $100m in a new pilot facility to make the active pharmaceutical ingredients (APIs) …

Jazz Pharmaceuticals will build its first in-house manufacturing facility in Ireland after years of relying on outsourcing to meet its …

India-based generic manufacturer Ranbaxy Laboratories has been dealt a further blow as the US regulator has banned more of its …
The deaths of dozens of patients as a result of the contaminated heparin incident in 2008 casts a long shadow …

AstraZeneca’s UK workers are facing more disruption following the company’s decision to close down a laboratory in Brixham focussing on …
Representatives of India’s pharma sector pledged to meet the government’s target of raising exports to $25 billion by 2016, as …
German contract development and manufacturing organisation (CDMO) Vetter says it is planning to invest over $100 million across its production …
Johnson & Johnson’s path back to regulatory compliance in its manufacturing operations has hit another snag after the firm was …

Solvay has reached an agreement to sell its peptide subsidiary Peptisyntha SA to the holding company behind contract manufacturing organisation …